Dynavax (DVAX) Misses Q3 EPS by 15c

November 7, 2016 6:11 AM EST

Get access to the best calls on Wall Street with StreetInsider.com's Ratings Insider Elite. Get your Free Trial here.

Dynavax (NASDAQ: DVAX) reported Q3 EPS of ($0.90), $0.15 worse than the analyst estimate of ($0.75). Revenue for the quarter came in at $162 thousand versus the consensus estimate of $2.44 million.

For earnings history and earnings-related data on Dynavax (DVAX) click here.

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In

Related Categories


Related Entities


Add Your Comment